Company / Free Cash Flow
EXACT SCIENCES CORP Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$356.8M
FY2025
5-year range
-$438.0M / $356.8M
FY2021-FY2025
Trend
+378.6%
vs FY2024
Sector context
#50 of 145
Health Care
What the data says
Free Cash Flow changed +379% YoY in FY2025, a notable deviation from the 9-year average annual change of +15%.
Based on SEC 10-K filings.
$357M in FY2025 with a 5-year CAGR of +38.0%.
Improved from $32M to $357M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +38.0%
- 10-Year CAGR
- -
Sector benchmark
#50 of 145 in Health CareTop 34% of 145This company $356.8M Sector average $770.9M
▼
-53.7% below sector average
Key checks
Key Insights
- EXACT SCIENCES CORP's free cash flow has grown for 3 consecutive years.
- 5-year CAGR of +38.0%, indicating consistent growth.
- In FY2025, free cash flow increased 378.6% year-over-year.
- Ranks #50 out of 145 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $356.8M | +378.6% |
| FY2024 | $74.5M | +133.5% |
| FY2023 | $31.9M | +107.3% |
| FY2022 | -$438.0M | -84.0% |
| FY2021 | -$238.0M | -433.3% |
| FY2020 | $71.4M | +125.1% |
| FY2019 | -$284.3M | -29.8% |
| FY2018 | -$219.0M | -82.2% |
| FY2017 | -$120.2M | +17.1% |
| FY2016 | -$144.9M | +6.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026